Similar articles

• The multiple risk factor intervention trial (MRFIT): implications for nurses.

  Ackerman AM, Froman D, Becker DM. Ackerman AM, et al. Prog Cardiovasc Nurs. 1987 Jul-Sep;2(3):92-9. Prog Cardiovasc Nurs. 1987. PMID: 3313379 Clinical Trial. No abstract available.
• Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.

  [No authors listed] [No authors listed] Prim Care. 1980 Mar;7(1):175-9. Prim Care. 1980. PMID: 6992178 Clinical Trial.
• [Possibilities and strategies for prevention of ischemic heart disease. Risk factors, trials, mass and individual strategies].

  Menotti A. Menotti A. G Ital Cardiol. 1989 Sep;19(9):770-7; discussion 778-86. G Ital Cardiol. 1989. PMID: 2612823 Italian. No abstract available.
• Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.

  Rautaharju PM, Neaton JD. Rautaharju PM, et al. Clin Invest Med. 1987 Nov;10(6):606-15. Clin Invest Med. 1987. PMID: 3326700 Review.
• Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.

  Labreche DG. Labreche DG. Clin Pharm. 1988 Aug;7(8):592-603. Clin Pharm. 1988. PMID: 3048850 Review. No abstract available.